ArticleJAMA network open2019

Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.

Mary Farrant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.